PTEN and thyroid cancer, nonmedullary, 2: We have previously described a mouse model of FTC whereby we utilized thyroid-specific expression of HrasG12V and homozygous Pten inactivation in mice to achieve concomitant MAPK and PI3K/Akt pathway activation.